212 related articles for article (PubMed ID: 9632811)
1. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis.
Scotto C; Deloulme JC; Rousseau D; Chambaz E; Baudier J
Mol Cell Biol; 1998 Jul; 18(7):4272-81. PubMed ID: 9632811
[TBL] [Abstract][Full Text] [Related]
2. Concerted regulation of wild-type p53 nuclear accumulation and activation by S100B and calcium-dependent protein kinase C.
Scotto C; Delphin C; Deloulme JC; Baudier J
Mol Cell Biol; 1999 Oct; 19(10):7168-80. PubMed ID: 10490652
[TBL] [Abstract][Full Text] [Related]
3. Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53.
Delphin C; Ronjat M; Deloulme JC; Garin G; Debussche L; Higashimoto Y; Sakaguchi K; Baudier J
J Biol Chem; 1999 Apr; 274(15):10539-44. PubMed ID: 10187847
[TBL] [Abstract][Full Text] [Related]
4. The protein kinase C activator, phorbol ester, cooperates with the wild-type p53 species of Ras-transformed embryo fibroblasts growth arrest.
Delphin C; Baudier J
J Biol Chem; 1994 Nov; 269(47):29579-87. PubMed ID: 7961944
[TBL] [Abstract][Full Text] [Related]
5. The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma.
Lin J; Yang Q; Wilder PT; Carrier F; Weber DJ
J Biol Chem; 2010 Aug; 285(35):27487-27498. PubMed ID: 20587415
[TBL] [Abstract][Full Text] [Related]
6. The calcium-dependent interaction between S100B and the mitochondrial AAA ATPase ATAD3A and the role of this complex in the cytoplasmic processing of ATAD3A.
Gilquin B; Cannon BR; Hubstenberger A; Moulouel B; Falk E; Merle N; Assard N; Kieffer S; Rousseau D; Wilder PT; Weber DJ; Baudier J
Mol Cell Biol; 2010 Jun; 30(11):2724-36. PubMed ID: 20351179
[TBL] [Abstract][Full Text] [Related]
7. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction.
Tsoporis JN; Izhar S; Leong-Poi H; Desjardins JF; Huttunen HJ; Parker TG
Circ Res; 2010 Jan; 106(1):93-101. PubMed ID: 19910580
[TBL] [Abstract][Full Text] [Related]
8. The giant protein AHNAK is a specific target for the calcium- and zinc-binding S100B protein: potential implications for Ca2+ homeostasis regulation by S100B.
Gentil BJ; Delphin C; Mbele GO; Deloulme JC; Ferro M; Garin J; Baudier J
J Biol Chem; 2001 Jun; 276(26):23253-61. PubMed ID: 11312263
[TBL] [Abstract][Full Text] [Related]
9. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
Pohl U; Wagenknecht B; Naumann U; Weller M
Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
[TBL] [Abstract][Full Text] [Related]
10. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
Martinez J; Georgoff I; Martinez J; Levine AJ
Genes Dev; 1991 Feb; 5(2):151-9. PubMed ID: 1995413
[TBL] [Abstract][Full Text] [Related]
11. The Ca(2+)-dependent interaction of S100B(beta beta) with a peptide derived from p53.
Rustandi RR; Drohat AC; Baldisseri DM; Wilder PT; Weber DJ
Biochemistry; 1998 Feb; 37(7):1951-60. PubMed ID: 9485322
[TBL] [Abstract][Full Text] [Related]
12. A search for inhibitors of S100B, a member of the S100 family of calcium-binding proteins.
Markowitz J; MacKerell AD; Weber DJ
Mini Rev Med Chem; 2007 Jun; 7(6):609-16. PubMed ID: 17584159
[TBL] [Abstract][Full Text] [Related]
13. Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.
Markowitz J; Rustandi RR; Varney KM; Wilder PT; Udan R; Wu SL; Horrocks WD; Weber DJ
Biochemistry; 2005 May; 44(19):7305-14. PubMed ID: 15882069
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of p53 transcriptional activity by the S100B calcium-binding protein.
Lin J; Blake M; Tang C; Zimmer D; Rustandi RR; Weber DJ; Carrier F
J Biol Chem; 2001 Sep; 276(37):35037-41. PubMed ID: 11454863
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion.
Knippschild U; Oren M; Deppert W
Oncogene; 1996 Apr; 12(8):1755-65. PubMed ID: 8622896
[TBL] [Abstract][Full Text] [Related]
16. Structural changes in the C-terminus of Ca2+-bound rat S100B (beta beta) upon binding to a peptide derived from the C-terminal regulatory domain of p53.
Rustandi RR; Baldisseri DM; Drohat AC; Weber DJ
Protein Sci; 1999 Sep; 8(9):1743-51. PubMed ID: 10493575
[TBL] [Abstract][Full Text] [Related]
17. p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis.
de Belle I; Huang RP; Fan Y; Liu C; Mercola D; Adamson ED
Oncogene; 1999 Jun; 18(24):3633-42. PubMed ID: 10380885
[TBL] [Abstract][Full Text] [Related]
18. Design of Inhibitors for S100B.
Markowitz J; Mackerell AD; Carrier F; Charpentier TH; Weber DJ
Curr Top Med Chem; 2005; 5(12):1093-108. PubMed ID: 16248785
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.
Markowitz J; Chen I; Gitti R; Baldisseri DM; Pan Y; Udan R; Carrier F; MacKerell AD; Weber DJ
J Med Chem; 2004 Oct; 47(21):5085-93. PubMed ID: 15456252
[TBL] [Abstract][Full Text] [Related]
20. Theoretical study on binding of S100B protein.
Gieldon A; Mori M; Del Conte R
J Mol Model; 2007 Nov; 13(11):1123-31. PubMed ID: 17713798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
